Search for: "Kirin v. Kirin"
Results 21 - 40
of 83
Sorted by Relevance
|
Sort by Date
5 Jan 2017, 4:11 am
While many of us were recovering from excessive helpings of turkey and Christmas pudding, a fascinating interim decision was handed down by Mr Justice Carr on 29 December in the biosimilars battle of Fujifilm Kyowa Kirin Biologics Co., Ltd and Others v AbbVie Biotechnology Limited [2016] EWHC 3383 (Ch). [read post]
3 Mar 2010, 5:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Cozaar (Losartan), Hyzaar (Hydrochlorothiazide; Losartan) – US: Teva prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva v Kathleen Sebelius (FDA Law Blog) (SmartBrief) Nexavar (Sorafenib) - India: More on Bayer patent linkage - Supreme Court admits special leave petition filed by Bayer… [read post]
3 Mar 2010, 5:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Cozaar (Losartan), Hyzaar (Hydrochlorothiazide; Losartan) – US: Teva prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva v Kathleen Sebelius (FDA Law Blog) (SmartBrief) Nexavar (Sorafenib) - India: More on Bayer patent linkage - Supreme Court admits special leave petition filed by Bayer… [read post]
29 Apr 2015, 7:24 pm
The class action lawsuit (Parent v. [read post]
13 Mar 2017, 3:12 am
On 2 March, the AmeriKat, as a keen prowler of the Daily Cause list, warms up for the following day’s court decision in the first trial between Fujifilm Kyowa Kirin Biologics Co., Ltd and Others v AbbVie Biotechnology Limited by summarising the latest timeline events.BREAKING: High Court grants declaration that products obvious/anticipated at claimed priority datesFollowing AmeriKat’s notice, Eibhlin Vardy timely analysed the High Court’s decision… [read post]
8 Nov 2017, 5:29 am
While noting the embarrassment and difficulty in commenting on your own cases, he explained that the difficulty with Kirin Amgen is that it is difficult to reconcile with the approach in Improver Corp v Remington Consumer Products Ltd [1990] FSR 181 - if it really all comes down to a matter of claim interpretation, then you don't need to go into the three Improver questions. [read post]
8 Mar 2017, 9:26 am
On 2 March, the AmeriKat, as a keen prowler of the Daily Cause list, warms up for the following day’s court decision in the first trial between Fujifilm Kyowa Kirin Biologics Co., Ltd and Others v AbbVie Biotechnology Limited by summarising the latest timeline events.BREAKING: High Court grants declaration that products obvious/anticipated at claimed priority datesFollowed AmeriKat’s notice, Eibhlin Vardy timely analyzes the High Court’s decision on 3 March that… [read post]
17 Jul 2017, 3:39 pm
This GuestKat has noted with interest comments which suggest that this case opens the way to a doctrine of "file wrapper estoppel" in the UK, but wonders whether the case really goes much further than existing UK case law which has admitted reference to the file in cases of "admissions against interest" - see for example Rohm & Haas v Collag [2002] F.S.R. 28 and Furr v Truline [1985] F.S.R. 553. [read post]
11 Apr 2016, 2:38 am
Batman v. [read post]
13 Jul 2017, 8:47 am
The judgment comes as a surprise, as the previously established UK case law had over time firmly done away with the idea of ‘pith and marrow’ infringement, culminating in the seminal House of Lords judgment in Kirin-Amgen v Hoechst Marion Roussel [2004] UKHL 46. [read post]
13 Jul 2017, 8:47 am
The judgment comes as a surprise, as the previously established UK case law had over time firmly done away with the idea of ‘pith and marrow’ infringement, culminating in the seminal House of Lords judgment in Kirin-Amgen v Hoechst Marion Roussel [2004] UKHL 46. [read post]
18 Apr 2013, 3:37 am
But this is a narrow exception to the general rule that a person will not be bound by the outcome of proceedings to which he is not a party: Skyparks v Marks, Powell v Wiltshire, Seven Arts v Content. iii) A direct commercial interest in the outcome of the litigation is insufficient to make someone a privy: Kirin-Amgen v Boehringer Mannheim. iv) Whether members of the same group of companies are privies or not depends on the facts: Special Effects. [read post]
19 Jan 2018, 3:58 am
Readers interested in patent law will be familiar with last summer's decision of the UK Supreme Court in Actavis v Eli Lilly [2017] UKSC 48. [read post]
30 Jul 2015, 9:50 am
That is what today's decision addresses.Appeal to the Supreme CourtThe Court of Appeal has refused leave for Smith & Nephew to appeal to the Supreme Court, because it considered that there is no significant point of general public importance at stake, since it has done no more than apply the established principles of claim construction from Kirin Amgen (Kirin Amgen Inc v Hoechst Marion Roussel Ltd [2004] UKHL 46, [2005] RPC 9) to the case before it. [read post]
24 Dec 2008, 9:00 am
Last week, Mr Justice Floyd delivered his judgment in the case of ratiopharm & Sandoz v Napp Pharmaceuticals, but the IPKat has been taking a while to digest this very long and complicated judgment. [read post]
22 Jan 2017, 11:49 am
Seeking an ArrowArrow declarations can be granted: Fujifilm v AbbVieGuestKat Eibhlin Vardy discusses Fujifilm Kyowa Kirin Biologics Co., Ltd v AbbVie Biotechnology Ltd & Anor [2017] EWCA Civ 1, which involves two appeals, both raising the question of whether a Court can grant a so called ‘Arrow declaration’, i.e. a declaration that “a product was old or obvious in patent law terms at a particular date”.Guest Post - China's Patent… [read post]
18 Jan 2017, 3:34 am
Qiao Yongzhong's book “Maintenance time and the industry development of patents -- empirical research with evidence from China”Biosimilars battle in clearing the way - Fujifilm v AbbVie continuesFull low down on the interim decision handed down by Mr Justice Carr on 29 December in the biosimilars battle of Fujifilm Kyowa Kirin Biologics Co., Ltd and Others v AbbVie Biotechnology Limited [2016] EWHC 3383 (Ch).15 fully-funded IP PhD positions are calling for… [read post]
26 Jun 2015, 12:30 am
This Kat blogged last year about the masterful and erudite judgment of Mr Justice Arnold in the case of Actavis v Lilly (judgment on BAILII here), concerning pemetrexed. [read post]
10 Jun 2023, 4:02 pm
The third panel (photo: Neil Graveney)Trevor Cook (photo: Neil Graveney)Trevor Cook recalled that 20 years ago his team appealed to the House of Lords in Kirin-Amgen. [read post]
26 Nov 2015, 8:12 am
Per the precedent set in Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2004] UKHL 46 (and other cases since), the question is "...what the person skilled in the art would have understood the Patentee to be using the language of the claim to mean". [read post]
